Novo CEO pressed by Senate to chop costs of weight problems, diabetic issues drugs CEO Lars Fruergaard Jørgensen informed lawmakers the corporate would consider new talks with insurers in regards to the listing price ranges of Wegovy and copyright when they pledge to keep the medicines on their own formularies. https://ayahealthcareaddress52840.blogpayz.com/30716864/the-smart-trick-of-healthcare-news-that-no-one-is-discussing